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Abstract
Obesity and gestational diabetes mellitus (GDM) are increasing worldwide and may compromise female sexual function. We
hypothesize that among GDM patients in the third trimester of pregnancy, those with excess body fat would have worse
female sexual function scores than normal weight women. Our aim was to assess the sexual function of overweight
compared to normal weight women with GDM. This was a cross-sectional survey involving 143 Brazilian women with GDM
in the third trimester of pregnancy: 76 were overweight (pre-pregnancy body mass index-BMI$25.0 Kg/m2) and 67 were
normal weight (BMI 18.5–24.9 Kg/m2). Participants were recruited from March 2010 to April 2013 at the antenatal clinic of a
single public tertiary teaching institution. The Female Sexual Function Index (FSFI) questionnaire was used to assess sexual
function. Overall, 51.7% of the 143 participants were at risk for sexual dysfunction symptoms (FSFI scores#26); this rate was
significantly higher among overweight compared to normal weight women (60.5% versus 41.8%, p = 0.038). Mean total FSFI
scores were significantly lower in overweight compared to normal weight women (21.769.2 versus 24.968.0, p = 0.029).
Compared to normal weight women, overweight participants had lower mean scores in desire (3.461.2 versus 4.061.4,
p = 0.007) and lubrication (3.862.0 versus 4.561.6, p = 0.023). According to these results, overweight women with GDM in
the third trimester of pregnancy have lower female sexual function scores than normal weight women with the same
disorder.
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Introduction
Sexual dysfunction symptoms are frequent during pregnancy.
They are attributed to physical [1,2,3], psychological [4],
relationship [5,6], sociocultural and religious [6,7] factors, as well
as to the common fears and myths about potential harms of sexual
intercourse on pregnancy or the fetus [3,7,8,9,10,11]. All phases of
the female sexual response cycle, including desire, arousal and
orgasm [12] can be compromised in pregnant women, especially
during the third trimester of pregnancy [8,13,14,15].
Gestational diabetes mellitus (GDM) is defined as glucose
intolerance that begins during pregnancy [16]. It affects from 1%
to 14% of all pregnant women depending on the diagnostic
criteria used and population characteristics and it is the most
frequent endocrine disorder of pregnancy [17]. Due to the
increasing prevalence of obesity, one of the main risk factors for
GDM [18,19], the prevalence of GDM is also expected to increase
over the next years, both in developed and developing countries
[20]. Recent studies [21,22,23] have investigated the prevalence of
sexual dysfunction symptoms in women with GDM. Investigators
hypothesized that the many adjustments associated with the
diagnosis of GDM, as well as the added stress related to increased
risks of maternal and perinatal complications, could affect the
sexual function of these women [24]. While some studies
confirmed this hypothesis [23], others did not identify significant
differences in sexual function scores of women with and without
GDM in the third trimester of pregnancy [21,22]. These
controversial findings could in part be due to differences in
population characteristics, including the prevalence of obese
women in these studies.
Obesity has been shown to compromise the sexual function of
reproductive age women [25,26,27,28]. Obese pregnant women
are at higher risk for depression and anxiety [29,30,31], and lower
quality of life [32,33], factors that increase the likelihood for sexual
dysfunction symptoms [34]. According to the latest national
demographic survey, 60% of reproductive age women (15–49
years) in Brazil are overweight (body mass index - BMI.24.9 Kg/
m) and one third of these women are obese (BMI$30 Kg/m 2)
[35].
There are studies on the sexual function of women with GDM
and of obese pregnant and non-pregnant women
[21,22,23,25,26,27,36]. However, to the best of our knowledge,
there are no previous studies which investigated the sexual
function of obese women with GDM. We hypothesize that among
GDM patients in the third trimester of pregnancy, those with
excess body fat would have worse female sexual function scores
than those of normal body weight.
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Aim
To assess and compare the sexual function of third trimester
overweight and normal weight women with GDM.
Material and Methods
Design and Data Collection
This was a cross-sectional study involving women with a
diagnosis of GDM managed at a large public university setting in
Sa˜o Paulo, Brazil, during a three-year period (2010–2013). As part
of their routine antenatal care and following international
recommendations [16], all women managed in the antenatal care
clinics of this university undergo a 75 g 2-hours oral glucose
tolerance test (OGTT) between 24 and 28 weeks of gestation to
diagnose GDM. Pregnant women with normal results (fasting
,92 mg/dL, 1 hour post-load ,180 mg/dL and 2 hour post-
load ,153 mg/dL) continue to be managed in their usual
antenatal care clinics. Those with at least one abnormal glucose
value (equal or greater than the aforementioned levels) receive a
diagnosis of GDM [37] and are referred to a specialized diabetes
antenatal care clinic within the university where they are managed
by a multi-professional team (obstetrician, endocrinologist, nurses,
dietitian, psychologist and physical therapist) until delivery. At this
specialized clinic, all women with a diagnosis of GDM receive the
same type of care, regardless of their BMI. Women with normal
OGTT results continue being managed at the regular antenatal
care unit, in another building.
Potential participants were approached while waiting for their
routine visits at this diabetes clinic. Inclusion criteria were: 20
years of age or older, singleton pregnancy, gestational age 28
weeks or more (based on ultrasound), diagnosed with GDM at
least 4 weeks before and pre-pregnancy BMI$18.5 Kg/m2 (based
on their self-reported pre-pregnancy weight and measured height).
Only women who were in a stable relationship with the same man
for at least six months were eligible to participate. Those in sexual
abstinence due to a medical recommendation (e.g. to treat vaginal
infections or placenta previa, premature rupture of membranes,
threatened preterm labor) were not eligible. Women taking
antihypertensive medication or medications that can interfere
with sexual function (such as antidepressants, tranquillizers, or
hormones) were also excluded, as well as those with a current or
previous history of psychiatric disorder (e.g. depression, schizo-
phrenia, and neuroses), substance abuse (alcohol or illicit drugs),
pregnancy resulting from rape, admission to the hospital in the last
30 days and absent or sexually unavailable partner in the last
month. Based on their prepregnancy BMI, the participants were
divided in two groups: normal weight (BMI 18.5–24.9 kg/m2) and
overweight (BMI ($25 Kg/m2) [38]. The health personnel caring
for these women in the specialized antenatal care unit were
blinded to the results of the questionnaires.
Ethics Statement
All participants gave written informed consent S1 and the study
was approved by the Ethics Committee of Sa˜o Paulo Federal
University (Process n. 0281/10).
Details of the Questionnaires
Participants were asked to fill individual, anonymous, written
questionnaires. Information collected included age, self-reported
race, education, marital status, religion, occupation, family
income, parity, family planning, gestational age and pre-pregnan-
cy BMI. Information regarding the date of GDM diagnosis,
current gestational age, use of insulin and their most recent HbA1c
level were collected from their antenatal charts. Gestational age
was based on menstrual dates confirmed through obstetric
ultrasounds.
All participants were asked to answer the Brazilian version of
the Female Sexual Function Index (FSFI), a self-responsive
questionnaire, with 19 questions [39]. This questionnaire is
accepted as a valid tool to measure female sexual function, has
good internal consistency (Cronbach’s alpha 0.791 to 0.914) and
evaluates all phases of the female sexual cycle (desire, arousal, and
orgasm), as well as sexual satisfaction, and dyspareunia in the last
four weeks [39,40]. Individual scores for each question range from
a minimum of 0 or 1 to a maximum of 5. Domain scores are
obtained by adding individual question scores and multiplying
these by a specific factor. The full scale score is obtained by adding
the six domain scores and ranges from 2 to 36, with higher scores
reflecting a better sexual function. Women with a total score #26
are classified as being at risk for sexual dysfunction [41]. Only the
desire domain has an established cutoff; it is scored on a 10-point
scale, with final score #5 indicating sexual desire dysfunction
symptoms (according to personal communication to the main
author). This questionnaire has been extensively used to assess
sexual function in pregnancy [8,15,22,42,43,44]. Each participant
took an average of 15 minutes to fill the questionnaires and those
who did not answer all questions of the FSFI were excluded from
the study.
Statistical Aspects
Based on the 59% prevalence of sexual dysfunction symptoms
among adult Brazilian women with GDM in the third trimester of
pregnancy [22] and assuming that overweight women would have
a 40% higher prevalence of this disorder, with an a= 0.05 and a
b= 90%, the study would need to recruit 62 participants in each
group (normal and overweight). Participant characteristics are
presented descriptively and compared between the two groups
using two-tailed Student’s t or Chi-square tests. Differences in
mean FSFI scores between the two groups were assessed using
Student’s t test. P values p,0.05 were considered significant.
Statistical analyses were performed using InStat 3 (Statistical
Services Centre, University of Reading, UK).
Main Outcome Measures
Main outcomes were mean total FSFI scores, mean individual
scores of each FSFI domain and the prevalence of patients with
low sexual function scores (FSFI#26) in the two groups (normal
and overweight).
Results
A total of 155 women were invited to participate, 12 were
excluded (four declined, three were using antihypertensive
medications, two were in sexual abstinence during the last month
because their husbands did not want to engage in sexual activities;
three were in sexual abstinence due to medical recommendations)
resulting in 143 participants included in the final analyses: 67
normal weight and 76 overweight. Within the overweight group,
there were 30 pre-obese (BMI$25–29.9 Kg/m2) and 46 obese
(BMI$30 Kg/m2) women. Since mean total FSFI scores of these
two subgroups did not differ significantly (21.369.4 and 21.969.2,
respectively, p = 0.784), they were combined in a single ‘‘over-
weight’’ group for further analyses.
The main characteristics of the participants were similar among
normal and overweight women (Table 1). Most were married,
catholic, multipara, employed, had at least 9 years of formal
education, a mean monthly family income between 340–1020 US
dollars and reported that their pregnancy had not been planned.
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Over 75% of the participants were being treated only through diet
at the moment of the survey.
The mean total FSFI score of the 143 GDM was 23.368.6.
Over half of the participants (n = 74) women scored #26 in the
FSFI questionnaire and were therefore classified as being at risk
for sexual dysfunction symptoms (Table 2). A total of 46
overweight women scored #26 on the FSFI compared to 28 of
the normal weight women (60.5% versus 41.8%, respectively
p = 0.038) (Table 2). Mean desire domain scores were significantly
lower in overweight compared to normal weight patients (3.461.2
versus 4.061.4, p = 0.007). The proportion of overweight women
reporting problems in desire (domain score #5) was significantly
higher than normal weight women: 48.7% versus 28.3%,
respectively (p = 0.021). Overweight women also had significantly
lower scores for the lubrication domain, compared to normal
weight women (3.862.0 versus 4.561.6, respectively p = 0.023)
(Table 2). The complete dataset with detailed information of all
143 participants is available upon request.
Discussion
The mean total FSFI scores of our 143 GDM patients were low.
This finding has been previously reported in studies with GDM
patients [21,22,23] and is also common among healthy pregnant
women in the third trimester of pregnancy [8,13,14,15]. Over
50% of all women in this survey scored below the cutoff used to
Table 1. Main characteristics of 143 women with GDM in the third trimester of pregnancy.
Variable
Normal weight BMI 18.5–24.9 Kg/m2
(n =67) Overweight group BMI$25 Kg/m2 (n=76) P value
Age, years 32.266.6 33.465.0 0.219*
Gestational age, weeks 32.863.4 32.563.2 0.588*
Prepregnancy BMI, Kg/m2 22.462.4 31.163.9 0.0001*
Time since diagnosis of GDM, weeks 8.964.5 9.664.8 0.372*
Marital Status
Married** 63 (94.0) 71 (93.4)
Single or divorced 4 (6.0) 5 (6.6) 0.100+
Religion
Catholic 33 (49.3) 46 (60.5)
Protestant 23 (34.3) 18 (23.7)
Other/none 11 (16.4) 12 (15.8) 0.327+
Education, years
,9 11 (16.4) 18 (23.7)
9 to 12 46 (68.7) 50 (65.8)
.12 10 (14.9) 8 (10.5) 0.468+
Race
White 20 (29.9) 34 (44.8)
Black 9 (13.4) 11 (14.5)
Mixed 38 (56.7) 31 (40.1) 0.136+
Employment
Housewife 18 (26.9) 28 (36.8)
Employed 49 (73.1) 48 (63.2) 0.203+
Family income6 (minimum wage per month)
,3 2 (3.0) 3 (3.9)
1 a 3 43 (64.2) 42 (55.3)
.3 22 (32.8) 31 (40.1) 0.555+
Parity
0 25 (37.3) 18 (23.7)
1 20 (29.9) 30 (39.4)
2 or more 22 (32.8) 28 (36.8) 0.192+
Unplanned pregnancy 46 (68.7) 56 (73.4) 0.633+
Currently using insulin 14 (20.9) 18 (23.7) 0.843+
**Or common law marriage.
*Student’s t-test.
+Chi-square test.
6One minimum wage represents approximately US$302,67.
Values presented as N (%) or mean (Standard Deviation [SD]).
GDM= gestational diabetes mellitus.
doi:10.1371/journal.pone.0095094.t001
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classify women as being at risk for sexual dysfunction. Similarly,
Souza et al. [23] reported that 67% of his 33 GDM patients were at
risk for sexual dysfunction and had significantly lower mean total
FSFI scores than their 88 healthy pregnant women (23.6 vs. 26.5,
p = 0.03, respectively). However these authors included only
women in the second trimester of pregnancy (20 to 25 weeks)
and did not evaluate the effect of maternal adiposity on these
indices.
As hypothesized, overweight GDM patients had a more
compromised sexual function than normal weight GDM patients,
with significantly lower mean total FSFI scores and a higher
prevalence of participants with sexual dysfunction symptoms.
Although overweight women scored lower in all domains, only
desire and lubrication were the phases of the sexual cycle that
explained poorer sexual functioning. Our findings suggest that
obesity may be a risk factor for poor sexual function among
women with GDM. Obesity in pregnancy has been associated with
lower quality of life, especially in the physical and mental domains
[32,33], with daytime sleepiness [33] and with higher levels of
anxiety [30] and depressive symptoms [30,31]. These findings can
help to explain the lower sexual function of our obese GDM
patients compared to our normal weight GDM patients.
The finding that overweight GDM patients are at a higher risk
for sexual dysfunction can have implications for practice. The
team of health professionals caring for these patients in our setting
is discussing the possibility of creating specific interventions for
them, including multidisciplinary group counseling to discuss
obesity and changes in the couple’s sexual life during pregnancy.
This type of intervention has not been specifically tested in obese
women but has shown promising results in pregnant women in
general. According to an Iranian study, after participating in four
weekly sexual education classes, the mean FSFI scores of 41
healthy pregnant women went from 22.6 (67.9) to 26.6 (64.3),
p = 0.0001 [45].
A strong point of our study was the use of the FSFI
questionnaire, a validated instrument to assess female sexual
function [39], which has been extensively used in studies involving
pregnant women [8,15,22,42,44,46]. An additional strong point
was that our participants were homogeneous in relation to other
variables, besides BMI, which could affect female sexual function
[47].
We acknowledge that use of additional questionnaires to
evaluate mental symptoms and quality of life of the participants
could have enriched our study. Finally, our findings cannot be
generalized to GDM patients of other socioeconomic strata or
cultural contexts.
Conclusion
Overweight GDM patients in the third trimester of pregnancy
have lower female sexual function scores than their normal weight
counterparts. Desire and lubrication were the phases of the sexual
cycle with the lowest scores among overweight women. More
studies, involving women of other social and cultural contexts are
needed to confirm these findings.
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Table 2. Sexual function scores1 of 143 women with GDM in the third trimester of pregnancy, according to prepregnancy body
mass index.
Normal weight BMI 18.5–24.9 (n =67) Overweight BMI$25 (n =76) P value
Women with scores #26 28 (41.8) 46 (60.5) 0.038**
Mean total score% 24.968.0 21.769.2 0.029*
Domains
Desire+ 4.061.4 3.461.2 0.007*
Arousal6 3.961.4 3.461.6 0.052*
Lubrication6 4.561.6 3.862.0 0.023*
Orgasm6 4.061.8 3.662.0 0.210*
Satisfaction6 4.461.7 3.962.1 0.118*
Dyspareunia6 4.162.0 3.762.1 0.251*
1. Scores obtained on the Female Sexual Function Index questionnaire [40].
% Scores range from 2 to 36; total score #26 suggest risk for sexual dysfunction [41].
** Chi-square test.
*Student’s t-test.
+Scores range from 1.2 to 6.
6Scores range from 0 to 6.
6Scores range from 0.8 to 6.
Values presented as N (%) or mean (Standard Deviation [SD]).
doi:10.1371/journal.pone.0095094.t002
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